Mucosal-associated invariant T-cell function is modulated by programmed death-1 signaling in patients with active tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 3, 2014, Pages 329-339

  Jiang, Jing ^a   Wang, Xinjing ^a   An, Hongjuan ^a   Yang, Bingfen ^a   Cao, Zhihong ^a   Liu, Yanhua ^a   Su, Jinwen ^a   Zhai, Fei ^a   Wang, Ruo ^a   Zhang, Guangyu ^a   Cheng, Xiaoxing ^a  

^a 309TH HOSPITAL OF PLA   (China)

Author keywords

Immunity; Mucosal associated invariant T cells; Tuberculosis

Indexed keywords

GAMMA INTERFERON; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MUCOSAL ASSOCIATED INVARIANT T CELL; PLEURA EFFUSION; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULOSIS; TUBERCULOUS PERITONITIS; TUBERCULOUS PLEURISY; APOPTOSIS; CASE CONTROL STUDY; IMMUNITY; IMMUNOLOGY; LUNG TUBERCULOSIS; MUCOSAL IMMUNITY; MUCOSAL-ASSOCIATED INVARIANT T CELLS; NONPARAMETRIC TEST;

IMMUNITY; MUCOSAL-ASSOCIATED INVARIANT T CELLS; TUBERCULOSIS;

ADULT; APOPTOSIS; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, MUCOSAL; MALE; PERITONITIS, TUBERCULOUS; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TUBERCULOSIS; TUBERCULOSIS, PLEURAL; TUBERCULOSIS, PULMONARY;

EID: 84907287298     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201401-0106OC     Document Type: Article

References (40)

1. Glaziou P, Falzon D, Floyd K, Raviglione M. Global epidemiology of tuberculosis. Semin Respir Crit Care Med 2013;34:3-16.
2. Philips JA, Ernst JD. Tuberculosis pathogenesis and immunity. Annu Rev Pathol 2012;7:353-384.
3. Korbel DS, Schneider BE, Schaible UE. Innate immunity in tuberculosis: myths and truth. Microbes Infect 2008;10:995-1004.
4. Behar SM, Divangahi M, Remold HG. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy? Nat Rev Microbiol 2010;8:668-674.
5. Cooper AM, Khader SA. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 2008; 226:191-204.
6. Winslow GM, Cooper A, Reiley W, Chatterjee M, Woodland DL. Early T-cell responses in tuberculosis immunity. Immunol Rev 2008;225:284-299.
7. Gold MC, Lewinsohn DM. Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat Rev Microbiol 2013;11:14-19.
8. Le Bourhis L, Mburu YK, Lantz O. MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol 2013;25: 174-180.
9. Patel O, Kjer-Nielsen L, Le Nours J, Eckle SB, Birkinshaw R, Beddoe T, Corbett AJ, Liu L, Miles JJ, Meehan B, et al. Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nat Commun 2013;4:2142.
10. López-Sagaseta J, Dulberger CL, McFedries A, Cushman M, Saghatelian A, Adams EJ. MAIT recognition of a stimulatory bacterial antigen bound to MR1. J Immunol 2013;191:5268-5277.
11. Dusseaux M, Martin E, Serriari N, Péguillet I, Premel V, Louis D, Milder M, Le Bourhis L, Soudais C, Treiner E, et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 2011;117:1250-1259.
12. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, Bhati M, Chen Z, Kostenko L, Reantragoon R, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012;491:717-723.
13. Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, Chen Z, Eckle SB, Uldrich AP, Birkinshaw RW, Patel O, et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosalassociated invariant T cells. J Exp Med 2013;210:2305-2320.
14. Le Bourhis L, Martin E, Péguillet I, Guihot A, Froux N, Coré M, Lévy E, Dusseaux M, Meyssonnier V, Premel V, et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 2010;11: 701-708. [Published erratum appears in Nat Immunol 11:969. Huang, Xhouxiong (added).]
15. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J, Winata E, Swarbrick GM, Chua WJ, Yu YY, et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 2010;8:e1000407.
16. Bird L. Mucosal immunology: bait for MAIT cells identified. Nat Rev Immunol 2010;10:539.
17. Meierovics A, Yankelevich WJ, Cowley SC. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc Natl Acad Sci USA 2013;110:E3119-E3128.
18. Le Bourhis L, Dusseaux M, Bohineust A, Bessoles S, Martin E, Premel V, Coré M, Sleurs D, Serriari NE, Treiner E, et al. MAIT cells detect and efficiently lyse bacterially-infected epithelial cells. PLoS Pathog 2013;9:e1003681.
19. Chua WJ, Truscott SM, Eickhoff CS, Blazevic A, Hoft DF, Hansen TH. Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infect Immun 2012;80:3256-3267.
20. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990;142: 725-735. [Published erratum appears in Am Rev Respir Dis 142:1470.]
21. Yang B, Wang X, Jiang J, Cheng X. Involvement of CD244 in regulating CD41 T cell immunity in patients with active tuberculosis. PLoS One 2013;8:e63261.
22. Jiang J, Wang X, Wang X, Cao Z, Liu Y, Dong M, Tong A, Cheng X. Reduced CD27 expression on antigen-specific CD41 T cells correlates with persistent active tuberculosis. J Clin Immunol 2010; 30:566-573.
23. Wang X, Cao Z, Jiang J, Niu H, Dong M, Tong A, Cheng X. Association of mycobacterial antigen-specific CD41 memory T cell subsets with outcome of pulmonary tuberculosis. J Infect 2010;60:133-139.
24. Leeansyah E, Ganesh A, Quigley MF, Sönnerborg A, Andersson J, Hunt PW, Somsouk M, Deeks SG, Martin JN, Moll M, et al. Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 2013;121:1124-1135.
25. Gold MC, Eid T, Smyk-Pearson S, Eberling Y, Swarbrick GM, Langley SM, Streeter PR, Lewinsohn DA, Lewinsohn DM. Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress. Mucosal Immunol 2013;6:35-44.
26. Walker LJ, Kang YH, Smith MO, Tharmalingham H, Ramamurthy N, Fleming VM, Sahgal N, Leslie A, Oo Y, Geremia A, et al. Human MAIT and CD8aa cells develop from a pool of type-17 precommitted CD81 T cells. Blood 2012;119:422-433.
27. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-2254.
28. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. Tumor necrosis factor-a is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-572.
29. Bean AG, Roach DR, Briscoe H, France MP, Korner H, Sedgwick JD, Britton WJ. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 1999;162:3504-3511.
30. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-1104.
31. Núñez Martínez O, Ripoll Noiseux C, Carneros Martín JA, González Lara V, Gregorio Marañón HG. Reactivation tuberculosis in a patient with anti-TNF-a treatment. Am J Gastroenterol 2001;96:1665-1666.
32. Cosgrove C, Ussher JE, Rauch A, Gärtner K, Kurioka A, Hühn MH, Adelmann K, Kang YH, Fergusson JR, Simmonds P, et al. Early and nonreversible decrease of CD16111/MAIT cells in HIV infection. Blood 2013;121:951-961.
33. Wherry EJ. T cell exhaustion. Nat Immunol 2011;12:492-499.
34. Zinselmeyer BH, Heydari S, Sacristán C, Nayak D, Cammer M, Herz J, Cheng X, Davis SJ, Dustin ML, McGavern DB. PD-1 promotes immune exhaustion by inducing antiviral T cell motility paralysis. J Exp Med 2013;210:757-774.
35. Shin H, Blackburn SD, Intlekofer AM, Kao C, Angelosanto JM, Reiner SL, Wherry EJ. A role for the transcriptional repressor Blimp-1 in CD81 T cell exhaustion during chronic viral infection. Immunity 2009; 31:309-320.
36. Alvarez IB, Pasquinelli V, Jurado JO, Abbate E, Musella RM, de la Barrera SS, García VE. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J Infect Dis 2010;202:524-532.
37. Jurado JO, Alvarez IB, Pasquinelli V, Martínez GJ, Quiroga MF, Abbate E, Musella RM, Chuluyan HE, García VE. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 2008;181:116-125.
38. Wang X, Cao Z, Jiang J, Li Y, Dong M, Ostrowski M, Cheng X. Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis. J Infect 2011;62:292-300.
39. Gérart S, Sibéril S, Martin E, Lenoir C, Aguilar C, Picard C, Lantz O, Fischer A, Latour S. Human iNKT and MAIT cells exhibit a PLZFdependent proapoptotic propensity that is counterbalanced by XIAP. Blood 2013;121:614-623.
40. Lanzavecchia A, Sallusto F. Understanding the generation and function of memory T cell subsets. Curr Opin Immunol 2005;17:326-332.